Juniper Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch JNP and buy or sell other stocks, ETFs, and their options commission-free!About JNP
Catalent JNP, Inc. engages in the research and development of drugs and therapeutics. It offers analytical characterization and pre-formulation testing; formulation development; and clinical manufacturing of capsules and tablets.
CEOJohn R. Chiminski
CEOJohn R. Chiminski
Employees—
Employees—
HeadquartersSomerset, New Jersey
HeadquartersSomerset, New Jersey
Founded1986
Founded1986
Employees—
Employees—
JNP Key Statistics
Market cap127.71M
Market cap127.71M
Price-Earnings ratio-115.00
Price-Earnings ratio-115.00
Dividend yield—
Dividend yield—
Average volume81.86K
Average volume81.86K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.25
52 Week high$13.25
52 Week low$4.30
52 Week low$4.30
Stock Snapshot
With a market cap of 127.71M, Juniper Pharmaceuticals(JNP) trades at $11.48. The stock has a price-to-earnings ratio of -115.00.
Juniper Pharmaceuticals(JNP) stock opened on 2025-12-07 at —. The price climbed to — and dipped to —.
Juniper Pharmaceuticals(JNP) shares are trading with a volume of 0, against a daily average of 81.86K.
In the last year, Juniper Pharmaceuticals(JNP) shares hit a 52-week high of $13.25 and a 52-week low of $4.30.
In the last year, Juniper Pharmaceuticals(JNP) shares hit a 52-week high of $13.25 and a 52-week low of $4.30.